InflaRx N.V.

NASDAQ:IFRX

Biotechnology

Healthcare
$1.09 -0.82%

-$0.02 today

Market cap
$160.63M
Beta
2.44
P/E (TTM)
-2.7
EPS (TTM)
-$0.59
52W Low $0.74High $2.95

Volume 0.66M

Average 1.80M

Income Statement

Follow revenue through to earnings.

Revenue

$29,331.00

FY 2025 · Annual

-82.3% YoY

Operating Income

-$48.26M

FY 2025 · Annual

Net Income

-$45.63M

FY 2025 · Annual

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0063.09K165.79K29.33K
Cost of Revenue00532.26K3.32M7.27M
Gross Profit00(469.17K)(3.15M)(7.24M)
Gross Margin——-743.7%-1900.8%-24677.9%
Research & Development35.7M37.53M41.02M35.36M25.72M
Selling, General & Admin11.43M14.34M16.12M19.33M17.56M
Operating Expenses47.63M32.24M44.13M49.75M41.02M
Depreciation & Amortization669.43K596.6K567.78K485.11K419.48K
EBITDA(44.94M)(28.84M)(42.06M)(45.55M)(45.16M)
EBITDA Margin——-66674.3%-27476.7%-153976.3%
Operating Income(47.63M)(32.24M)(44.59M)(52.91M)(48.26M)
Operating Margin——-70685.6%-31911.4%-164525.5%
Interest Income109.39K608.68K3.8M3.2M1.77M
Interest Expense24.77K45.25K35.63K20.66K37.69K
Other Income / Expenses2M2.75M1.93M6.85M2.64M
Income Before Tax(45.63M)(29.48M)(42.67M)(46.06M)(45.62M)
Pre-Tax Margin——-67630.7%-27781.8%-155540.2%
Income Tax Expense0005.22K12.28K
Net Income(45.63M)(29.48M)(42.67M)(46.06M)(45.63M)
Net Margin——-67630.7%-27785.0%-155582.1%
EPS (Basic)(1.10)(0.61)(0.78)(0.78)(0.66)
EPS (Diluted)(1.10)(0.61)(0.78)(0.78)(0.66)
Weighted Avg Shares41.63M44.21M54.94M58.92M67.29M
Weighted Avg Shares (Diluted)41.63M44.21M54.94M58.92M67.29M

IFRX Earnings Waterfall · TTM

NASDAQ:IFRX · Revenue to Net Income

Key Ratios

EPS$-0.61
Gross Margin2132.9%
Net Margin-14161.8%
P/E Ratio-1.6
P/S Ratio673.2

Analysis

$29.3K of revenue converted into -$42.9M of net income for the selected period. Gross margin is 2132.9% and net margin is -14161.8%, showing how much revenue survives after costs and taxes. EPS is $-0.61, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 6, 2026
6-K6-K filingNov 3, 2026
6-K6-K filingNov 3, 2026
6-K6-K filingOct 22, 2026
SC 13GSC 13G filingAug 17, 2026

How much revenue does IFRX generate?

InflaRx N.V. (IFRX) reported $29,331.00 of revenue in fiscal 2025.

Is IFRX profitable?

InflaRx N.V. (IFRX) reported -$45.63M of net income, with a net margin of -155582.1%.